Nilotinib-cap-150mg-28's-blister-label (Nilotinib Cap 150mg 28s Blister Label)
Nilotinib Capsule
Product Images NDC 72205-237
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Nilotinib (NDC 72205-237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Nilotinib-cap-150mg-28s-inner-crtn-label (Nilotinib Cap 150mg 28s Inner Crtn Label)
This text provides information about Nilotinib Capsules, a prescription medication used to treat certain types of cancer. It includes details on dosage, administration instructions, storage conditions, and safety precautions. The text also mentions the manufacturer, distributor, contact information, and a reminder to dispense the accompanying Medication Guide to each patient.*
Nilotinib-cap-150mg-28s-outer-crtn-label (Nilotinib Cap 150mg 28s Outer Crtn Label)
This text is a label for Nilotinib Capsules, with instructions on how to take the medication, storage instructions, dosage information, and contact details for more information. It advises taking the capsules on an empty stomach, provides the dosage of 150 mg per capsule, presents details about the manufacturer and distributor, as well as information on how to access the Medication Guide.*
Nilotinib-cap-200mg-28's-blister-label (Nilotinib Cap 200mg 28s Blister Label)
Nilotinib-cap-200mg-28s-inner-crtn-label (Nilotinib Cap 200mg 28s Inner Crtn Label)
This text provides important information about Nilotinib Capsules, a prescription medication. It includes instructions for use, dosage guidelines, storage recommendations, and contact information for further inquiries. Patients are advised to take the capsules on an empty stomach, avoiding food for at least 2 hours before and 1 hour after taking a dose. The text also includes details on how to open and close the packaging of the capsules. Overall, this text serves as a guide for pharmacists and patients using Nilotinib Capsules.*
Nilotinib-cap-200mg-28s-outer-crtn-label (Nilotinib Cap 200mg 28s Outer Crtn Label)
This is a description of Nilotinib Capsules, a prescription medicine to be taken on an empty stomach. Each capsule contains 200 mg of nilotinib and is part of a pack with 4 individual blister packs containing 28 capsules each. It is essential to avoid food for at least 2 hours before and 1 hour after taking a dose of nilotinib capsules. The medication guide should be dispensed to each patient. Storage should be between 20°C to 25°C with excursions permitted between 15°C and 30°C. The medicine is manufactured by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals LLC. For more information, visit www.novadozpharma.com or call 1-855-668-2369.*
Nilotinib-cap-50mg-120s-cntr-label (Nilotinib Cap 50mg 120s Cntr Label)
Each capsule contains 50 mg of nilotinib, a medication that should be stored between 20°C to 25°C (68°F to 77°F). Excursions are permitted between 15°C and 30°C (59°F and 86°F). It is recommended to take these capsules on an empty stomach, avoiding food for at least 2 hours before and 1 hour after taking a dose. The medication guide is available at the manufacturer's website.*
Nilotinib-cap-fig-1 (Nilotinib Cap Fig 1)
Nilotinib-cap-fig-2 (Nilotinib Cap Fig 2)
Nilotinib-cap-structure (Nilotinib Cap Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
